Chemoinformaics analysis of Methyl 2-hexenoate
| Molecular Weight | 128.171 | nRot | 3 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 0 |
| Exact Molecular Weight | 128.084 | nRing | 0 |
| Solubility: LogS | -2.309 | nHRing | 0 |
| Solubility: LogP | 2.967 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 21.2955 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.547 |
| Synth | 1.573 |
| Natural Product Likeliness | 0.834 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.033 |
| HIA | 0.004 |
| CACO-2 | -4.264 |
| MDCK | 0.0000245 |
| BBB | 0.986 |
| PPB | 0.793082 |
| VDSS | 1.048 |
| FU | 0.275926 |
| CYP1A2-inh | 0.852 |
| CYP1A2-sub | 0.626 |
| CYP2c19-inh | 0.185 |
| CYP2c19-sub | 0.17 |
| CYP2c9-inh | 0.148 |
| CYP2c9-sub | 0.68 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.104 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.104 |
| CL | 8.609 |
| T12 | 0.656 |
| hERG | 0.06 |
| Ames | 0.008 |
| ROA | 0.077 |
| SkinSen | 0.844 |
| Carcinogencity | 0.124 |
| EI | 0.985 |
| Respiratory | 0.177 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.951486 |